BNP Paribas Financial Markets
TELO icon

BNP Paribas Financial Markets’s Telomir Pharmaceuticals TELO Stock Holding History

BNP Paribas Financial Markets’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257 Sell
201
-5
-2% -$7 ﹤0.01% 5738
2026
Q1 		$268 Hold
206
– – ﹤0.01% 5606
2025
Q4 		$274 Sell
206
-141
-41% -$203 ﹤0.01% 5538
2025
Q3 		$482 Sell
347
-914
-72% -$1.38K ﹤0.01% 5315
2025
Q2 		$1.58K Sell
1,261
-3
-0.2% -$7 ﹤0.01% 5097
2025
Q1 		$4.08K Sell
1,264
-3,143
-71% -$13.7K ﹤0.01% 4885
2024
Q4 		$18.2K Buy
4,407
+1,363
+45% +$6.42K ﹤0.01% 4744
2024
Q3 		$19.5K Buy
3,044
+2,644
+661% +$12.9K ﹤0.01% 3749
2024
Q2 		$1.92K Buy
+400
New +$2.5K ﹤0.01% 3816

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

BNP Paribas Financial Markets's TELO Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Telomir Pharmaceuticals (TELO) stake by 2.4% in Q2 2026, selling an estimated $7 and leaving 201 shares worth $257. The position accounts for ﹤0.01% of the portfolio, ranked #5738.

BNP Paribas Financial Markets first reported a position in TELO in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.5K in Q3 2024. 24 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • BNP Paribas Financial Markets held 201 shares of Telomir Pharmaceuticals worth $257 as of Q2 2026.
  • BNP Paribas Financial Markets sold 5 Telomir Pharmaceuticals shares in Q2 2026, an estimated $7.
  • Telomir Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5738 holding.
  • BNP Paribas Financial Markets first reported a position in Telomir Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • BNP Paribas Financial Markets's Telomir Pharmaceuticals position peaked at $19.5K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.